Development of expectations and their influence on treatment response in patients with rheumatoid arthritis

• Conditions: M05; M06; Seropositive rheumatoid arthritis; Other rheumatoid arthritis

• Registration Number: DRKS00017042
• Lead Sponsor: Poliklinik und Funktionsbereich für Rheumatologie und Hiller-Forschungszentrum, Universitätsklinikum Düsseldorf

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-26
• Study Completion: 2019-12-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 204

Inclusion Criteria

rheumatoid arthritis according to ACR/EULAR classifications criteria, age >18 years, sufficient German language skills

Exclusion Criteria

insufficient German language skills, no written informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment response at 3 months (change in DAS28)

Secondary Outcome Measures

Name	Time	Method
Change in heart rate variabiliy at 3 months, change in neuropeptide Y and vasoactive intestinal peptide - concentrations at 3 months